Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Generali

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Quaderni Di Storia Della Medicina E Della Scienza|January 1, 1985
[Not Available]D Generali
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies?G Roviello, D Generali
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance statusG Roviello, C Pacifico, K Polom, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2017
Need for randomized clinical trials testing targeted therapies in malignant pleural mesotheliomaN Sobhani, G Roviello, S P Corona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevationA Berruti, M Tucci, D Generali, et al.
Medical Oncology (Northwood, London, England)|June 16, 2017
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Cancer Chemotherapy and Pharmacology|June 13, 2019
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancerG Roviello, F U Conter, E Mini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
EGFR mutations in exons 18-21 in sporadic breast cancerD Generali, R Leek, S B Fox, et al.
Medical Oncology (Northwood, London, England)|May 21, 2017
Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Breast Cancer Research and Treatment|February 16, 2020
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancersS P Corona, M Bortul, S Scomersi, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Quaderni Di Storia Della Medicina E Della Scienza|January 1, 1985
[Not Available]D Generali
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies?G Roviello, D Generali
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance statusG Roviello, C Pacifico, K Polom, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2017
Need for randomized clinical trials testing targeted therapies in malignant pleural mesotheliomaN Sobhani, G Roviello, S P Corona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevationA Berruti, M Tucci, D Generali, et al.
Medical Oncology (Northwood, London, England)|June 16, 2017
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Cancer Chemotherapy and Pharmacology|June 13, 2019
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancerG Roviello, F U Conter, E Mini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
EGFR mutations in exons 18-21 in sporadic breast cancerD Generali, R Leek, S B Fox, et al.
Medical Oncology (Northwood, London, England)|May 21, 2017
Advances in systemic therapy for metastatic breast cancer: future perspectivesS P Corona, N Sobhani, A Ianza, et al.
Breast Cancer Research and Treatment|February 16, 2020
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancersS P Corona, M Bortul, S Scomersi, et al.
Pageof 6